At On/Go, we're building a new-age COVID infrastructure – grounded by data – that brings us one-step closer to a post-quarantine future.
Let the next phase in our fight against COVID begin.
On/Go's Diagnostics as a Service (DaaS) solution automatically collects, stores and analyzes testing results so that you can provide relevant data and information for decision makers in real time.
Our data acts like NOOA for weather - helping us all see the bigger picture in anticipation and plan, prevent, predict and protect our society.
On/Go’s proven superior technology gives organizations and individuals the ability to predict, prevent, AND protect against the next wave. Combining regular, best-in-class testing and sophisticated data modeling, we can crush COVID, together.
Because beating COVID means staying ahead of it. Let’s outsmart Covid and stay active, by being proactive.
Fill out the form and our sales team will get back to you shortly.
Our platform provides real-time COVID test results that give you the precise knowledge to act immediately. With our solution, you can quickly implement targeted, data based interventions based on real-time data.
Get tests quickly shipped to individuals' homes, or provide testing on site. With results in just minutes, you can take see data and take actions, quickly.
We're here to support you every step of the way. From account setup to proctoring services to results management, we'll make sure you can quickly get your organization up and running on our platform.
Our top-rated iOS and Android mobile app delivers an intuitive testing experience. With over 30,000 five-star reviews, the On/Go app provides rapid test results, tracks your testing history and lets you easily share results with those who need to know.
Get the appThe On/Go and On/Go One tests have not been FDA cleared or approved but have been authorized by FDA under an Emergency Use Authorization (EUA). These products have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
The On/Go COVID-19 Antigen Self Test and the On/Go One COVID-19 Antigen Home Tests are lateral flow chromatographic immunoassays intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19
